SmarterDividends

GMED vs MRK: Which Is the Better Dividend Stock?

As of Nov 22, 2026, MRK (Merck & Co., Inc.) screens as the stronger dividend stock, winning 3 of 4 head-to-head metrics. MRK offers the higher yield at 2.63%, MRK has the higher dividend-safety score.

Key facts: GMED vs MRK

Data as of · Source: SmarterDividends data

  • As of Nov 22, 2026, Merck & Co., Inc. (MRK) has the higher forward dividend yield at 2.63%, versus 0.00% for Globus Medical, Inc. (GMED).
  • By SmarterDividends' count as of Nov 22, 2026, GMED has raised its dividend for 0 consecutive years and MRK for 15.
Cite this page

SmarterDividends, "GMED vs MRK: Dividend Yield, Safety & Value Compared," updated Nov 22, 2026, https://smarterdividends.com/compare/gmed-vs-mrk

MetricGMEDMRK
Forward yield0.00%2.63%
Annual dividend$0.00$3.52
Payout ratio0%343%
Years of growth0 yr15 yr
5-yr dividend growth—6.7%
5-yr total return—74%
Dividend safety score—87 (A)
Fair value estimate—$132.83
Upside to fair value—-1%
Frequency—quarterly
Market cap$8.9B$329.7B
P/E ratio16.5135.1

Higher yield

MRK

2.63%

Safer dividend

MRK

Grade A

Faster growth

MRK

6.7%

GMED vs MRK FAQ

Is GMED or MRK a better dividend stock?

On the data, MRK wins more head-to-head categories (3 vs 1). MRK offers the higher yield (2.63%), while MRK has the stronger dividend-safety score. The right pick depends on whether you prioritise income, safety or value.

Which has a higher dividend yield, GMED or MRK?

MRK has the higher forward dividend yield at 2.63%, versus 0.00% for GMED.

Is GMED or MRK safer?

Compare each stock's payout ratio, growth streak and cut history on its detail page to judge safety.

See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.